dbo:abstract
|
- La métopimazine est une substance chimique de la famille des phénothiazines et des sulfones. Elle possède des propriétés pharmacologiques antiémétiques et neuroleptiques. C'est pourquoi elle est notamment utilisée dans la gastro-entérite et dans le cadre des chimiothérapies. Elle agit comme antagoniste de la dopamine. Sa balance bénéfices-risques est défavorable. (fr)
- Metopimazine (INN, USAN, BAN), sold under the brand names Nortrip, Vogalen, and Vogalene, is an antiemetic of the phenothiazine group which is used to treat nausea and vomiting. It is marketed in Europe, Canada, and South America. As of August 2020, metopimazine has been repurposed and is additionally under development for use in the United States for the treatment of gastroparesis. Metopimazine has antidopaminergic, antihistamine, and anticholinergic activity. However, it has also been described as a highly potent and selective dopamine D2 and D3 receptor antagonist. The D2 receptor antagonism of metopimazine is thought to underlie its antiemetic and gastroprokinetic effects. It is said to not readily cross the blood–brain barrier and hence to have peripheral selectivity, in contrast to metoclopramide but similarly to domperidone. Unlike domperidone however, metopimazine shows no hERG inhibition and hence is expected to have a more favorable cardiovascular profile. In contrast to metoclopramide, metopimazine does not interact with serotonin 5-HT3 and 5-HT4 receptors. (en)
- Metopimazyna (łac. metopimazinum) – organiczny związek chemiczny, lek o działaniu przeciwwymiotnym z grupy pochodnych fenotiazyny. (pl)
- Метопимазин — фенотиазиновое противорвотное средство. Препарат воздействует на рвотный центр, предотвращает тошноту и рвоту различного происхождения . (ru)
|
dbo:alternativeName
|
- Nortrip, Vogalen, Vogalene (en)
|
dbo:casNumber
| |
dbo:chEBI
| |
dbo:chEMBL
| |
dbo:drugbank
| |
dbo:fdaUniiCode
| |
dbo:kegg
| |
dbo:pubchem
| |
dbo:thumbnail
| |
dbo:wikiPageExternalLink
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 8023 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:atcPrefix
| |
dbp:atcSuffix
| |
dbp:c
| |
dbp:casNumber
| |
dbp:chebi
| |
dbp:chembl
| |
dbp:chemspiderid
| |
dbp:drugbank
| |
dbp:h
| |
dbp:iupacName
| |
dbp:kegg
| |
dbp:legalStatus
| |
dbp:n
| |
dbp:o
| |
dbp:pubchem
| |
dbp:routesOfAdministration
| |
dbp:s
| |
dbp:smiles
| |
dbp:stdinchi
| |
dbp:stdinchikey
|
- BQDBKDMTIJBJLA-UHFFFAOYSA-N (en)
|
dbp:synonyms
|
- EXP-999; NG-102; RP-9965 (en)
|
dbp:title
| |
dbp:titlestyle
| |
dbp:tradename
|
- Nortrip, Vogalen, Vogalene (en)
|
dbp:unii
| |
dbp:verifiedfields
| |
dbp:verifiedrevid
| |
dbp:width
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
rdf:type
| |
rdfs:comment
|
- La métopimazine est une substance chimique de la famille des phénothiazines et des sulfones. Elle possède des propriétés pharmacologiques antiémétiques et neuroleptiques. C'est pourquoi elle est notamment utilisée dans la gastro-entérite et dans le cadre des chimiothérapies. Elle agit comme antagoniste de la dopamine. Sa balance bénéfices-risques est défavorable. (fr)
- Metopimazyna (łac. metopimazinum) – organiczny związek chemiczny, lek o działaniu przeciwwymiotnym z grupy pochodnych fenotiazyny. (pl)
- Метопимазин — фенотиазиновое противорвотное средство. Препарат воздействует на рвотный центр, предотвращает тошноту и рвоту различного происхождения . (ru)
- Metopimazine (INN, USAN, BAN), sold under the brand names Nortrip, Vogalen, and Vogalene, is an antiemetic of the phenothiazine group which is used to treat nausea and vomiting. It is marketed in Europe, Canada, and South America. As of August 2020, metopimazine has been repurposed and is additionally under development for use in the United States for the treatment of gastroparesis. (en)
|
rdfs:label
|
- Métopimazine (fr)
- Metopimazine (en)
- Metopimazyna (pl)
- Метопимазин (ru)
|
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:isPrimaryTopicOf
| |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |